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Background and objectives: The objective of this experiment was to study the effect of CL 
316,243 (CL) (a highly selective β3-adrenergic receptor agonist) on cellular changes occurring 
in retroperitoneal white adipose tissue (RWAT) of lean and obese rats. 
Methods: Ten-month-old lean and obese Zucker rats were implanted subcutaneously with 
osmotic mini-pumps, infusing either saline or CL (1 mg/kg body weight/day) for 4 weeks. 
Results: There was no effect of CL on food intake. However, the resting metabolic rate in lean 
and obese rats increased by 55% and 96% per rat, respectively. Total RWAT weight decreased 
in both lean and obese rats under influence of CL treatment by 65% and 38%, respectively. Total 
body weight and body fat were lower in CL treated rats. Detection of uncoupling protein 1 (UCP1) 
in RWAT was confirmed qualitatively by both immunohistochemistry and immunofluorescence 
using a rabbit anti rat UCP1 antibody which showed the appearance of a marked increase of this 
protein in the adipose tissue. Stained semi-thin sections (0.5 µm) also demonstrated abundant 
nuclei in multilocular adipocytes, in endothelial cells associated with the vasculature, and in 
interstitial cells. In CL-treated obese rats, a clustering of several multilocular cells around the 
periphery of a white adipocyte was seen. 
Conclusion: These results indicate that treatment of both lean and obese Zucker rats with 
CL induces extensive remodeling of RWAT that includes shrinkage of white adipose tissue, 
appearance of abundant multilocular cells in RWAT together with the appearance of a marked 
increase of UCP, preferentially in lean rats. 
Keywords: brown adipose tissue, cellularity of adipose tissue, obesity, thermogenesis, uncou-
pling protein, Zucker rats
Introduction
β-adrenergic receptors have been classified as β1 and β2 since 1967.1 Rat adipocyte 
lipolysis was initially thought to be a β1-mediated process. However, recent evi-
dence shows that the receptor mediating lipolysis is neither β1 nor β2, but atypical 
in nature.2 These atypical receptors, now called β3-adrenoceptors, are found on the 
cell surface of both white and brown adipocytes where their stimulation promotes 
both lipolysis and energy expenditure in brown adipose tissue (BAT) and lipolysis in 
white adipose tissue (WAT).3 The thermogenesis function in BAT largely depends 
on an integral membrane protein located at the inner membrane of mitochondria that 
is called thermogenin or uncoupling protein one (UCP1).4,5 UCP1 is responsible for 
translocation of protons into the mitochondria and elevation of respiration rate without 
an increase in ATP synthesis which in turn induces energy dissipation as heat.6 It has 
been reported that a chronic administration of the β3-adrenergic agonists can induce 
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the ectopic expression of UCP in white fat and skeletal 
muscle. β3-adrenergic agonists can induce a functionally 
active UCP in fat and slow-twitch muscle fibers in rodents 
and humans7 except guinea pigs which lack β3-adrenergic 
receptors in their fat tissue.8
Development of thermogenic drugs for treatment of 
obesity has now focused on selective β3-adrenergic agonists. 
It has been postulated that thermogenic drugs might stimulate 
thermogenesis in BAT and induce lipolysis of WAT.4 In a 
previous study we demonstrated that the daily treatment of 
rats with CL 316,243 (CL), a highly selective β3-adrenergic 
agonist,9 for 4 weeks reversed the development of obesity 
induced by a high fat diet.10 This reversal of obesity was 
associated with an increase in metabolic rate (without any 
change in food intake) and an augmentation in mitochondrial 
proliferation, including an increase in the level of UCP in 
BAT. It was later discovered that there were several UCPs 
which are tissue specific and the one which is specific for 
adipose tissue was named UCP1. In the present work, we 
describe the effects of CL on energy balance, lipolysis, and 
cell type differentiation in WAT as well as in type II diabe-
tes in lean and obese Zucker rats. In addition, we document 
with both immunohistochemistry and immunofluorescence 
changes in the occurrence of UCP1 in WAT.
Material and methods
chemicals
CL (disodium(R, R)-5-)2-[[2-3-(3-chlorophenyl)-2-hydro-
xyethyl]-amino] propyl-1, 3-benzodioxole-2, 2-dicarboxylate 
(Figure 1) was a gift from American Cyanamid Company, 
Pearl River, New York, USA (Bloom et al 1992).2 All other 
chemicals were purchased from Sigma-Aldrich Co. (St Louis, 
MO, USA).
study design
All animal protocols were reviewed and approved by 
Pasteur Institute of Iran Animal Care and Use Commit-
tee. The study was performed over a period of 12 months 
between April 2012 and April 2013. All biochemical and 
histological assays where performed at both University of 
Ottawa and Pasteur Institute of Iran laboratories. Thirty obese 
fa/fa Zucker rats and 30 lean littermates were purchased at 
11 weeks of age from Charles River Canada and housed 
at 24°C in plastic cages containing wood chips with free 
access to food (with 14.5% energy from fat) and water. After 
animals reached 36 weeks of age, at which time WAT shows 
a large increase in number of mature white adipocytes,11,12 
food intake and body weight were measured weekly for 
4 weeks. Each group of rats was separated into three groups 
of ten animals. One group of ten, from both obese and lean 
Zucker rats, was killed immediately after separation (week 0, 
lean 4 and fatty 4). The rest of the rats were implanted sub-
cutaneously with mini-osmotic pumps (Alzet 2002; Alzet, 
Palo Alto, CA, USA) perfusing 0.5 µL/hour of either saline 
or CL (1 mg/kg body weight/day) for 2 weeks. Rats in all 
groups were then killed and retroperitoneal white adipose 
tissue (RWAT) was dissected. A small amount of tissue was 
placed in buffered formalin for both immunohistochemistry 
and immunofluorescence and the remainder of the tissue was 
kept on ice until it was homogenized and stored at -80°C 
for further assays. Some samples of RWAT were fixed in 
buffered glutaraldehyde solution (2% paraformaldehyde and 
2.5% glutaraldehyde) and after embedding in Epon, semi-
thin sections (0.5 µm) were cut and stained with methylene 
blue and azur II.13 We also took samples for measurement 
of cellularity, using Hirsch and Gallian’s method14 which 
measures the number of mature white adipocytes.
assays
Frozen tissue samples were homogenized in isolation medium 
[0.25 M sucrose, 0.2 mM dipotassium ethylenediaminetetraa-
cetic acid (EDTA), and 1.0 mM (4-(2-hydroxyethyl)-1-pipera-
zineethanesulfonic acid) (HEPES), in distilled water, pH 7.2].8 
Proteins were measured by a modified Lowry et al method as 
before.8,10 DNA was measured in delipidated WAT homoge-
nate with dye binding (Hoechst 33258) (Sigma-Aldrich Co.) 
fluorometric method and UCP1 in WAT was assessed by 
sodium dodecyl sulphate–polyacrylamide gel electrophoresis 
(SDS-PAGE) followed by Western blotting. 
energy expenditure
On day 12 after implantation, resting metabolic rate was 
measured using an oxygen analyzer (Beckman Industrial 
Oxygen Analyzer Model 755). Each rat was placed in a 
temperature controlled chamber at 24°C and airflow was 
regulated with a Brooks thermal mass flow meter (Brook 
Instrument Division, Emerson Electric, Hatfield, PA, USA). 
OH
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N
Figure 1 structure of cl 316,243.
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Oxygen concentration in the air flowing through the chamber 
was calculated using a computer program.15
Tissue fixation
Rats were killed by decapitation and RWAT was removed and 
fixed in 10% buffered formalin. After embedding the tissue in 
paraffin, thick sections (7 to 10 µm) were cut, deparaffinized 
and rehydration of the sections took placed as follows: sec-
tions rehydrated by immersion in xylene (twice for 5 minutes), 
100% ethanol (twice for 3 minutes), 95% ethanol (once for 
3 minutes), 70% ethanol (once for 3 minutes), and water (once 
for 5 minutes). Sections were then stained with hematoxylin 
and eosin (6 minutes incubation in filtered Delafield’s hema-
toxylin, rinsed in water, and immersed in alcohol [30% alco-
hol +1% HCL] for 3 seconds, washed in 1% lithium carbonate 
in water until the section was blue, washed in running water for 
10 minutes, placed in eosin for 2 minutes, dehydrated through 
95% alcohol [2 minutes], 100% alcohol [2 minutes, twice], 
and xylol [2 minutes], and mounted in permount).
immunohistochemistry
Deparaffinization and rehydration of sections were exactly 
the same as mentioned above. Antibody against rat UCP1 
was raised in rabbits and the sera was stored in glycerol 1:1 
at -20°C. Sections were incubated with the primary antibody 
to rat UCP1 diluted with TCT (1:100) (tris–HCl pH 8, 0.6% 
carrageenan and 0.3% Triton X-100) overnight at 4°C. The 
next day, sections were washed twice in TBS buffer (0.1 
M Tris and 0.14 M sodium chloride) for 7 minutes and 
incubated with a secondary antibody (donkey anti-rabbit 
immunoglobulin, biotinylated whole antibody) (Abcam, 
Cat#ab6801) diluted in TCT buffer (1:50) for 30 minutes. 
Sections were washed in TBS twice for 7 minutes and 
neutralized in 3% hydrogen peroxide diluted with TBS for 
10 minutes. Sections were washed again in TBS for 7 min-
utes and were then incubated with streptavidin-horseradish 
peroxidase conjugate diluted with TCT (1:50) for 30 min-
utes at room temperature (RT). They were washed in TBS 
twice for 7 minutes, then incubated with diaminobenzidine 
(Sigma-Aldrich Co.) (200 µg/100 mL TBS +700 µL 10% 
nickel chloride +10 µL hydrogen peroxide) for 12 minutes in 
the dark. Sections were then dehydrated in alcohol, cleared 
in xylol, and mounted in permount. 
Immunofluorescence
After deparaffinization and rehydration, sections were rinsed 
in phosphate buffered saline (PBS) for 2 minutes, and were 
then incubated with primary antibody to UCP1 for 40  minutes 
at RT. They were then washed three times and incubated 
with secondary antibody, biotinylated donkey anti rabbit 
immunoglobulin G (Abcam, Cat#ab6801), (1:100) for 30 
minutes at RT. Slides were washed three times and incubated 
with streptavidin fluorescein isothiocyanate (FITC) conjugate 
(eBioscience, Cat#11-4317) (1:30) for 40 minutes. They were 
rinsed again in PBS and incubated with propidium iodide 
(Biolegend, Cat# 421301) (1:3,000) for 2 minutes. Finally, 
they were rinsed in PBS and mounted.
Measurement of blood glucose, 
serum insulin and fatty acids (Fas)
Serum insulin was measured by enzyme-linked immunosorbent 
assay (ELISA) (Ultra Sensitive Rat Insulin kit, Morinaga 
Institute of Biological Science, Inc, Yokohama, Japan). 
Serum glucose was measured by a hexokinase/glucose-6- 
phosphate dehydrogenase method on a Coulter DACOS 
device (510 k Decisions, Irvine, CA, USA). Homeostasis 
model assessment was calculated as the product of fasting 
insulin (micro units per milliliter) and fasting glucose (micro-
moles per liter) divided by 22.5.16 Fasting serum insulin and 
homeostasis model assessment were used as markers of 
insulin resistance.17 Serum FAs were measured using an FAs 
assay kit (Hoffman-La Roche Ltd., Basel, Switzerland).
statistical analysis
Results are presented as means ± standard error of the mean 
(SEM). Statistical analysis used Instat software to do analysis 
of variance (ANOVA) followed by a Student Newman-Keuls 
test. Significant differences are based on P0.05.
Results
Four weeks’ treatment of rats with CL did not alter signifi-
cantly the final body weight of lean rats; however the body 
weight of obese Zucker rats treated with CL was slightly 
lower than control rats (Figure 2). There was no difference 
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Figure 2 Body weight in cl-treated or control lean or obese fa/fa rats. 
Notes: Bars are mean ± SEM for ten rats. No significant differences were observed.
Abbreviations: cl, cl 316,243; seM, standard error of the mean. 
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in food intake in drug treated and untreated rats in both lean 
and obese rats (data not shown).
The resting metabolic rates of rats treated with CL were 
increased by 96% in obese and 55% in lean rats based on their 
kilogram body weight, while there was no marked increase 
in their body temperature (37.3°C to 38.2°C) as compared 
to control rats (Figure 3).
RWAT weight was much greater in untreated obese 
fa/fa rats after 4 weeks feeding, however in CL-treated 
rats, it significantly decreased in both lean and obese rats 
(Figure 4).
Protein content of RWAT was substantially increased 
by the CL-treatment in both lean and fa/fa rats (Figure 5). 
In previous experiments we have shown that the treat-
ment of rats with CL stimulated thermogenesis in BAT 
by increasing the number of mitochondria and the amount 
of cytochrome oxidase and UCP in this tissue which is 
associated with a marked decrease of DNA concentration 
in WAT.18 
In this paper we report the specific effect of CL on 
WAT morphology and its relevance to type 2 diabetes. To 
investigate whether CL-treatment induces any changes of 
cell types in WAT, tissues were processed to assess the 
presence of multilocular cells and UCP in WAT. Blood 
samples were also assayed for differences in serum insu-
lin, blood glucose, and free acids levels in treated and 
untreated rats. 
Staining of WAT sections with hematoxylin and eosin 
showed the appearance of multilocular fat cells among white 
adipocytes (Figure 6). To establish the brown fat cell charac-
ter for these cells, we used immunohistochemistry to show 
that these multilocular cells contained UCP1, not visible at all 
in RWAT of the saline-treated rats (Figure 7). Higher power 
light microscopy of semi-thin sections showed the multilocu-
lar cells to have darkly stained cytoplasm, numerous small 
lipid droplets, and large pale nuclei with a prominent nucleoli, 
characteristic of brown adipocytes (Figure 8). To demonstrate 
the presence of brown adipocytes containing UCP in WAT 
of CL-treated rats we used confocal microscopy technique 
using a LEICA confocal laser scanning microscope (Leica 
Microsystems, Wetzlar, Germany). For this purpose we used 
10 µm paraffin sections labeled with antibody to rat UCP1 
and conjugated with FITC. Confocal micrographs showed 
appearance of abundant multilocular cells with numerous 
small lipid droplets in CL-treated lean rats (Figure 9). West-
ern blotting showed that RWAT of CL-treated rats contained 
a 32 kd protein, identified as UCP1, more abundant in lean 
rats than fa/fa rats (data not shown). 
Treatment with CL also decreased the serum insulin level 
in fa/fa rats. In oral glucose tolerance test, serum insulin and 
blood glucose levels were significantly higher in the obese 
rats treated with saline after feeding with 2 mg glucose/g 
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Figure 3 effect on metabolic rate in cl-treated or saline-treated lean or obese 
Zucker rats after 4 weeks treatment. 
Notes: Bars are mean ± SEM for four rats. *Significant values are based on P0.05.
Abbreviations: cl, cl 316,243; seM, standard error of the mean; min, minute.
60
50
40
30
20
10
0
Lean rats Obese 
fa/fa rats
R
W
AT
 w
ei
gh
t (
gr
am
)
Before treatment
4 weeks treatment 
with saline
4 weeks treatment 
with CL
*
*
Figure 4 effect of cl on rWaT weight in lean and obese rats. 
Notes: Bars are mean ± SEM for four rats. *Significant values are based on P0.05.
Abbreviations: cl, cl 316,243; seM, standard error of the mean; rWaT, 
retroperitoneal white adipose tissue. 
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Figure 5 Protein contents of rWaT. 
Notes: cl-treatment increased total protein in both lean and obese fa/fa rats 
significantly (*P0.001). 
Abbreviations: cl, cl 316,243; rWaT, retroperitoneal white adipose tissue.
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Figure 6 light micrographs of the appearance of multilocular adipocytes.
Notes: light micrographs of the appearance of multilocular adipocytes in 10 µm sections of rWaT in lean and fatty Zucker rats. (A) control lean rat (B) cl-treated lean 
rat (C) control fatty rat (D) cl-treated fatty Zucker rat. sections were stained with hematoxylin and eosin. abundant multilocular cells appeared in rWaT of cl-treated 
rats. Bars 20 µm. Magnification is ×400.
Abbreviations: cl, cl 316,243; rWaT, retroperitoneal white adipose tissue.
Figure 7 immunochemical detection of UcP in rWaT. 
Notes: sections (10 µm) were immunolabeled with an antibody specific to UCP. The black spots are immunoreactive UCP in WAT of both lean and fa/fa rats under CL-
treatment. (A) control lean rat; (B) cl-treated lean rats; (C) control fa/fa rat; (D) cl-treated fa/fa rat. Bars 20 µm. Magnification is ×400.
Abbreviations: cl, cl 316,243; rWaT, retroperitoneal white adipose tissue; UcP, uncoupling protein; WaT, white adipose tissue.
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Figure 8 higher power light microscopy of semi-thin sections of rWaT. 
Notes: semi-thin sections (0.5 µm) were cut and stained with methylene blue and azur ii. Prints show the multilocular cells with darkly-stained cytoplasm, numerous small 
lipid droplets and large pale nuclei. (A) control lean rat; (B) cl-treated lean rat; (C) control fa/fa rat; (D) cl-treated fa/fa rat. Bars 10 µm. Magnification ×2,000.
Abbreviations: cl, cl 316,243; rWaT, retroperitoneal white adipose tissue.
Figure 9 confocal micrographs of rWaT of lean rat treated with cl 316,243 (cl). 
Notes: appearance of multilocular cells with numerous small lipid droplets (shown in black) and abundant immunolabeled UcP stained with FiTc (green areas) in cl-treated 
lean rat. (A) rWaT of control lean rat; (B) rWaT of cl-treated lean rat; (C) side view of rWaT of control fa/fa rat; (D) side view  of rWaT of cl-treated fa/fa rat. Bars 
20 µm. Magnification is ×500.
Abbreviations: RWAT, retroperitoneal white adipose tissue; UCP, uncoupling protein; FITC, fluorescein isothiocyanate.
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body weight as compared with lean rats treated with saline. 
Treatment with CL significantly decreased both serum insulin 
and blood glucose levels in fa/fa rats (Figure 10A and B). 
Measurement of serum FAs also showed a marked decrease 
in obese rats treated with CL which was accompanied by 
normoglycemia and improvement of insulin resistance 
indicating that β3-adrenergic responsiveness is present in 
these rats (Figure 11). 
Discussion
The present study examined the effect of CL on cellular 
changes in RWAT for lean and obese Zucker rats. In this 
experiment the stimulatory effects of CL compound on ther-
mogenesis and adipocyte lipolysis were determined through 
biochemical assays, measurement of food intake, and resting 
metabolic rate. The results indicate that CL, a highly selective 
β3-adrenoceptor agonist,2,8 has anti-obesity effects on lean 
and obese rats without changing food intake. The effect of 
CL was associated with an increase in thermogenesis shown 
by an increased resting metabolic rate (66% in obese rats ver-
sus 39% in lean rats [Figure 3]), which eventually promotes 
leanness. An increase in energy expenditure induced by a 
β3-adrenoceptor agonist is likely to be occurring in brown 
adipocytes. 
Treatment with CL induced a remarkable atrophy of 
retroperitoneal fat depots in obese rats. However, lean rats 
did not show such a decrease of fat depots in their RWAT 
which could be due to the very low level of fat depots in these 
rats. Morphological studies showed that white adipocyte size 
in CL-treated rats was smaller than in control, and even less 
than in lean animals (data not shown). These data demon-
strate that under the influence of CL, fat cells lose their lipid 
content and become smaller, while the number of mature fat 
cells remains constant. A marked decrease in DNA content 
of RWAT (Figure 5) also shows that CL-treatment results 
in considerable apoptosis. 
One of the most important differences between white and 
brown adipocytes is the presence of UCP in the latter.19,20 
Thus, the presence of UCP in the white fat deposit of the 
CL-treated rats could be due to the transformation of white 
adipocytes into brown adipocytes, or to recruitment of 
dormant brown fat cells present in the white fat deposit. 
However the appearance of multilocular cells and UCP1 in 
WAT of obese rats was much lower than that in lean rats 
(Figures 6–8). That could be due to the existence of a lower 
number of precursor cells in obese animals since most fat 
cells in these rats are mature adipocytes.21,22 
In this study we have also demonstrated the correlation 
of β-adrenergic receptor stimulation and the improvement 
of serum insulin and blood glucose level in obese fa/fa 
rats. It has also been documented that the improvement of 
NIDDM in these animals by treatment with CL is linked 
with the suppression of TNF-α messenger ribonucleic acid 
expression in WAT.16
This study showed that the hyperplasticity characterized 
by an increased number of mature white adipocytes as well 
as insulin-resistance condition in genetically obese fa/fa rats 
can be improved by treatment with CL. The finding of an 
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Figure 10 (A) serum insulin and (B) blood glucose levels in both control and cl 316,243 treated rats.
Notes: Bars are mean ± SEM for ten rats. *Significant values are based on P0.05.
Abbreviations: cl, cl 316,243; seM, standard error of the mean; s, saline.
Se
ru
m
 F
A
s 
le
ve
l m
m
ol
/L
Serum FAs concentration
Lean rats Fa/fa rats
Saline
*
CL
0
1
2
3
4
5
6
Figure 11 serum fatty acids level in lean and obese rats treated with cl 316,243. 
Notes: Bars are mean ± SEM for ten rats. *Significant values are based on P0.05.
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increased amount of UCP1 in WAT could stimulate further 
investigation into the activation of thermogenesis in WAT 
through the synthesis of UCP1 in this tissue.
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